|Year : 2017 | Volume
| Issue : 52 | Page : 756-761
In vitro Cytotoxicity and apoptotic assay in HT-29 cell line using Ficus hispida Linn: Leaves extract
Jayalalitha Sathiyamoorthy, Natarajan Sudhakar
Department of Biotechnology, Dr. M.G.R. Educational and Research Institute University, Chennai, Tamil Nadu, India
|Date of Submission||19-Jul-2017|
|Date of Acceptance||28-Aug-2017|
|Date of Web Publication||31-Jan-2018|
Department of Biotechnology, Dr. M.G.R Educational and Research Institute University, Maduravoyal, Chennai - 600 095, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Ficus hispida Linn. (Family Moraceae), well-known beneficial medicinal shrub, has been traditionally used for the treatment of various diseases such as leukoderma. Objective: The aim of the present study is to investigate the efficacy of F. hispida ethanolic leaves extract for antiproliferative, apoptotic, cell cycle blockade, and wound healing. Materials and Methods: F. hispida leaves extract was treated with colorectal adenocarcinoma cancer cell line HT29 for 24 h with control. The cells were treated at varying concentration ranges of 15, 31, 62, 125, and 250 μg/ml each The cytotoxicity effect of leaves extract was studied by 3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyltetrazolium bromide assay and their anticancer activity was further evaluated using cell cycle analysis and wound scratch assay. Results: The end antiproliferative result showed that HT-29 cell viability decreases in a concentration-dependent manner and the growth inhibitory effect (IC50) values are obtained at a concentration of 125 μg. The increase in number of apoptotic cell was observed after treating HT-29 cells with the sample in double-staining methods. G0/G1 phase of the cell cycle was significantly blocked by the test sample followed by the G2/M phase in a negligible manner. In vitro cell wound closure or contracture was not significant when compared the sample against control group. Conclusion: F. hispida Linn. ethanolic leaves extract had shown to possess excellent cytotoxic effect through inducing apoptosis, especially causing cell cycle arrest at the G0/G1 phase.
Abbreviations used: HT 29: Human adenocarcinoma colorectal cell line; PBS: Phosphate Buffered Saline; FBS: Fetal Bovine Serum; DMEM: Dulbecco's Modified Eagles Medium; MTT: 3 [4, 5 dimethylthiazol 2 yl] 2, 5 diphenyltetrazolium bromide; NCCS: National Centre for Cell Sciences; DMSO: DiMethyl SulfOxide; PI: Propidium Iodide; AO: Acridine Orange;EB: Ethidium Bromide; IC: Inhibitory Concentration.
Keywords: Apoptosis, cancer, cytotoxicity, Ficus hispida, phytochemicals, plant extract
|How to cite this article:|
Sathiyamoorthy J, Sudhakar N. In vitro Cytotoxicity and apoptotic assay in HT-29 cell line using Ficus hispida Linn: Leaves extract. Phcog Mag 2017;13, Suppl S4:756-61
|How to cite this URL:|
Sathiyamoorthy J, Sudhakar N. In vitro Cytotoxicity and apoptotic assay in HT-29 cell line using Ficus hispida Linn: Leaves extract. Phcog Mag [serial online] 2017 [cited 2020 Jun 6];13, Suppl S4:756-61. Available from: http://www.phcog.com/text.asp?2017/13/52/756/224312
- The experiment tries to evaluate the effectiveness of F. hispida leaves extract as an antiproliferative, apoptotic,cell cycle inhibitor and wound healing agent. Results showed that F. hispida Linn extract own cytotoxic property by inducing apoptosis through cell cycle arrest.
| Introduction|| |
Cancer, an important cause of mortality word wide next to cardiovascular disease, is characterized by the deregulation of signaling pathways with an initial loss of controlled cell division and growth, cell invasion, and finally, result in metastasis. Apoptosis is the important mechanism that maintains tissue homeostasis through caspases leading to cell death and its regulations are altered in many of the pathological conditions such as cancer. A recent report indicated its incidence to be 94/100,000 people with an age-standardized rate in India, and about more than half of the Indian incidence globally. Lung, intestine, breast, prostate, pancreas, ovary, liver, bladder, blood cells, and bone are the most common human location site. The advent of modern cancer synthetic treatment procedures has a major drawback of expensiveness and carries a broad list of adverse effect such as anemia, appetite loss, bleeding and bruising (thrombocytopenia), constipation, diarrhea, edema, fatigue, and hair loss (alopecia) to congestive heart failure, coronary artery disease, arrhythmia, hypertension, lung problems, endocrine problem, bone and joint problem, brain and spinal cord problems, dental, oral, and vision problems. The World Health Organization (2001) has estimated that between 80% of the populations are treated through medicines or medicinal formulations obtained from plant sources. Moreover, plant sources (phytoextracts) are commonly employed in traditional medicine are thought to be safe, better alternative to synthetic drugs without any side effects, longer usage duration, and potential in targeting diseases., Hence, screening for phytochemical pharmacological properties from different traditional plants are necessitated to identify a more efficient chemotherapeutic drug with better efficacy to target different signaling pathway in a precise, specific, and sensitive way to control cancer proliferation and induce apoptosis.
Ficus hispida Linn. (Family Moraceae) is one such well-known beneficial medicinal shrub or moderate-sized plant growing in damp and shady areas found in India, Sri Lanka, Myanmar, Southern region of China, New Guinea, Australia, and Andaman island. Most of this plant parts are used as a treatment remedy for various ailments such as leukoderma, skin diseases, jaundice, and as antipoisonous by Indian traditional healers. Current literature survey had shown that various parts of the plants are beneficial as antimicrobial, anti-inflammatory, analgesic, antipyretic, antitussive, antiulcer wound healing, antidiabetes, gall bladder disease, antidiarrheal in rats (significant inhibitory activity against castor oil-induced), paracetamol-induced hepatotoxicity protective effect on rat, cancer cell lines (oral, colon and breast cancer) through phenanthroindolizidine alkaloid called O-methyltylophorinidine, cisplatin-induced nephrotoxicity, antihyperlipidemic, cardioprotective effect, and antioxidant.,,,,,,,,,, The above medical properties of the plants are due to the presence of phytochemical constituents include phenanthroindolizidine alkaloids, n-alkanes, coumarins and triterpenoids, hispidin, oleanolic acid, bergapten, β-amyrin and β-sitosterol, lupeol acetate, β-sitosterol, and β-amyrin acetate.,
However, the leaves are of particular interest in view of anticancer property, but till date, there is limited and incomplete research has been performed on this traditional plant. Moreover, screening of crude extract or phytochemical potential to induce apoptosis has not been properly elucidated in the past as it is the best strategy for developing a novel anticancer drug. Hence, the objective of the present study is to investigate the F. hispida leaves potential for their antiproliferative and apoptosis inducing activities on human adenocarcinoma colorectal (HT-29) cell line.
| Materials and Methods|| |
Trypsin was procured from Gibco, USA, while Phosphate Buffered Saline (PBS), Fetal Bovine Serum (FBS), Dulbecco's Modified Eagles Medium(DMEM), 3- [4, 5-dimethylthiazol-2-yl]-2, 5 diphenyltetrazolium bromide (MTT), penicillin-streptomycin, and ethidium bromide were purchased from Hi-Media Laboratories, Mumbai, India. Rest of the chemicals employed in the study was analytical grade.
Collection of Ficus hispida leaves and preparation of crude extract
The leaves of F. hispida Linn. were collected from Chennai. The plant specimen was deposited and authenticated by Prof. Jayaraman, Plant Anatomy Research Centre, West Tambaram, Chennai, bearing a voucher number PARC/2015/3210. The dried material was further subjected to a fine coarse powder using a blender, and then, the powder was stored in air-tight container for further use. Crude plant extract was prepared by Soxhlet extraction method. About 150 g of F. hispida Linn. leaf powder was weighed and macerated in 450 ml of ethanol. The powdered material was kept for occasional shaking for 72 h at room temperature. After 72 h, the supernatant was collected by filtration and the solvent was evaporated. The crude extract was stored in 4°C until further use.
Procurement of cancer cell lines
The HT-29 (human colorectal adenocarcinoma) cell line was initially procured from the National Centre for Cell Sciences (NCCS), Pune, India, and maintained in DMEM. The cell line was cultured in 25 cm2 tissue culture flask with DMEM supplemented with 10% FBS, L-glutamine, sodium bicarbonate and antibiotic solution containing: penicillin (100 U/ml), streptomycin (100 μg/ml). Cultured cell line was kept at 37°C in a humidified 5% CO2 incubator (VWR, USA). Two-day-old confluent monolayer of cells were trypsinized and the cells were suspended in 10% growth medium, 100 μl cell suspension (5 × 104 cells/well) was seeded in 96-well tissue culture plate and incubated at 37°C in a humidified 5% CO2 incubator for 24 h. The viability of cells was evaluated by direct observation of cells by Inverted phase contrast microscope and followed by MTT assay method.
Ethanolic plant extract compound stock and test concentration
About 1 mg of plant compound was added to 1 ml of Dimethyl Sulfoxide (DMSO) and dissolved completely by cyclomixer. After that, the extract solution was filtered through 0.22 μm millipore syringe filter to ensure the sterility. Different concentration of the test sample were prepared in serial dilution were 15, 31, 62, 125, and 250 μg in 100 μl of 5% DMEM. In short, after 24 h, the growth medium was removed, freshly prepared each plant extracts in 5% DMEM were five times serially diluted by two fold dilution (15, 31, 62, 125, and 250 μg in 100 μl of 5% DMEM) and each concentration of 100 μl were added in triplicates to the respective wells and incubated at 37°C in a humidified 5% CO2 incubator for 24 h.
In vitro anticancer and wound healing assay
3- [4, 5-dimethylthiazol-2-yl]-2, 5 diphenyltetrazolium bromide assay
The antiproliferative effect of ethanolic extract of F. hispida Linn. was assessed by the MTT assay against in HT-29 cell line. 15 mg of MTT was reconstituted in 3-ml PBS until completely dissolved and sterilized by filter sterilization. After 24 h of incubation period, the sample content in wells was removed. About 30 μl of reconstituted MTT solution was added to all test and cell control wells, the plate was gently shaken well, and then incubated at 37°C in a humidified 5% CO2 incubator for 4 h. After the incubation period, the supernatant was removed and 100 μl of MTT solubilization solution (DMSO) was added, and the wells were mixed gently by pipetting up and down to solubilize the formazan crystals. The absorbance values were measured using microplate reader at a wavelength of 570 nm., Ethanolic extract efficiency for cytotoxicity was measured in terms of growth inhibition percentage for different concentration using the below formula.
The percentage of growth inhibition was calculated using the formula:
Assessment of apoptosis by double staining
DNA-binding dyes Acridine Orange (AO) and Ethidium Bromide (EB) were used for the morphological detection of apoptotic and necrotic cells. AO is taken up by both viable and nonviable cells and emits green fluorescence if intercalated into double-stranded nucleic acid. Only nonviable cell takes EB and by intercalation into DNA emits red fluorescence. After treatment with IC50 of plant extracts at a final concentration for 24 h, the cells were washed by cold PBS, and then stained with a composition of 100 μg/ml each AO and EB for 10 min at room temperature. The stained cells were washed twice with 1X PBS and observed by a fluorescence microscope in blue filter of fluorescent microscope (Olympus CKX41 with Optika Pro5 camera).
Determination of DNA content and cell cycle distribution using flow cytometry
Monitoring a cell ability to proliferate is critical for assessing a cell's health during toxicity studies, and the most accurate method involves direct measurement of DNA synthesis. The MUSE cell cycle kit uses a previously mixed reagent of the nuclear DNA intercalating stains propidium iodide (PI) which discriminates cells at different stages of the cell cycle based on the differential DNA content in the presence of RNAase to increase the specificity of DNA staining in each phase (G0/G1, S and G2/M).
HT-29 colorectal cancer cells were cultured as per the standard procedures and treated with IC50 values of compounds for 24 h. The cell sample was transferred to a 12 mm × 75 mm polystyrene tube or 50 ml conical flask. The minimum recommended number of cells for fixation in a tube is 1 × 106 cells. The samples were then centrifuged at 3000 rpm for 5 min. The supernatant was removed without disturbing the pellet. After centrifugation, the cell pellet forms either a visible pellet or a white film on the bottom of the tube.
Appropriate volume of PBS was added to each tube (i.e., 1 ml of PBS per 1 × 106 cells) and the contents were mixed by pipetting several times or gently vortexing. The tubes were centrifuged at 3000 rpm for 5 min. The supernatant was discarded without disturbing the cell pellet, leaving approximately 50 μl of PBS per 1 × 106 cells. The pellet was resuspended in the residual PBS by repeated pipetting several times or gently vortexing. The resuspended cells were added drop wise into the tube containing 1 ml of ice cold 70% ethanol while vortexing at medium speed. The tube was capped and freezed at −20°C.
Staining of cell cycle
After the overnight incubation, the samples were centrifuged at 3000 rpm for 5 min at room temperature. The supernatant was removed and 250 μl PBS was added to the pellet. Then, the centrifugation was done again at the same rpm. To the pellet, 250 μl of muse cell cycle reagent was added after discarding the supernatant and incubated at dark for 30 min (light sensitive) followed by flow cytometry analysis. Gating was performed with reference to untreated control cells and samples were analyzed.
Scratch wound healing assay
Exponentially, growing cells were trypsinized and seeded at a density of 200,000 cells per well into 12-well plate for 24 h incubation (~90% confluence). The scratch wounds were made by a sterile 1 mL pipette tip through a premarked line. After removal of the resulting debris from five lineal scratches, the HT-29 cell monolayer was subsequently rinsed three times with PBS followed by incubation with sample for 24 h. The wound areas were displayed by taking images just above the interchanges between scratched wound areas and premarked lines and the effect of sample on wound closure was determined microscopically (×4 magnification, Olympus CKX41) after 24 h of incubation. The effect of sample on wound closure was captured using MRI-Image software.
All the experimental samples were done in triplicate to validate the test results. Statistical analyses were performed using latest SPSS version. The mean values of reading were obtained from the test replicate. The efficiency of the test sample was compared between treated and untreated HT-29 colorectal cancer cells by employing independent sample t-test and paired sample t-test. The P < 0.05 was considered as statistically significant.
| Result|| |
Measurement of cell viability
The experimental cells which showed the viability above 95% was carried out for further experiments.
3- [4, 5-dimethylthiazol-2-yl]-2, 5 diphenyltetrazolium bromide assay
Antiproliferative potential in terms of anticancer assessment was done on F. hispida for the cell viability against HT-29 cell line at varying concentration ranges of 0 μg, 15 μg, 31 μg, 62 μg, 125 μg, and 250 μg. The end result showed that HT-29 cell viability decreases in a concentration-dependent manner, and the growth inhibitory effect (IC50) values are obtained at a concentration of 125 μg [Figure 1].
|Figure 1: Cell viability percentage measured by 3-[4, 5-dimethylthiazol- 2-yl]-2, 5 diphenyltetrazolium bromide assay|
Click here to view
DNA-binding dyes acridine orange (AO) and ethidium bromide (EB) were used to test the ethanolic sample extract for the apoptosis induction ability by treating with HT-29 cells. The cells were divided into four categories as follows: live cells (normal green nucleus), early apoptotic (bright green nucleus with condensed or fragmented chromatin), late apoptotic (orange-stained nuclei with chromatin condensation or fragmentation), and necrotic cells (uniformly orange-stained cell nuclei). The test result showed the control cells and apoptotic cells as in [Figure 2]. The presence of necrotic cells was not observed in the experiment.
|Figure 2: (a) Control-HT-29 cells showing live cells stained with acridine orange. (b) Fluorescence image of HT-29 cells treated with ethanolic leaf extract of the Ficus hispida Linn|
Click here to view
Flow cytometry analysis
The efficiency of the ethanolic leaf extract on the cell cycle progression through apoptotic induction was measured by flow cytometry after staining with PI. The result shows that 52.4%, 24.9% and 18% of the cells were in G0/G1, S and G2/M phase of the cell cycle in the control cells. Flow cytometry DNA histogram had showed a peak at G0/G1 phase of the cell cycle. When we compared between control and IC50 test sample group, we observed a statistical significance at G0/G1 and G2/M phase of the cell cycle [Figure 3]. Thus, the result clearly indicates that the ethanolic leaf extract possess the inhibitory effect on cell cycle progression at G0/G1 phase and suggesting its interaction.
|Figure 3: (a) Cell cycle analysis of untreated cells. (b) DNA Content profile during various stages of cell cycle in ethanolic leaf sample treatment against HT-29 cell lines. (c) Comparison of DNA content between control and treated HT29 cells|
Click here to view
Wound scratch healing assay
HT-29 cell line was tested through the scratch assay to determine the capacity of these cells to migrate under phytoextract stimulus. The test drug at IC50 value showed negligible difference in closure of wound area when compared between the control after 24 h of treatment time as shown in [Figure 4].
|Figure 4: Wound closure after 24 h of treatment (control cells vs. treated cells)|
Click here to view
| Discussion|| |
Apoptosis, programmed cell death, and a well-structured physiological process to eliminate unregulated/abnormal or damaged cells remain as golden screening endpoint for discovering anticancer drugs. They are the common targets for currently clinically used and promising anticancer agents. It is more rational for the scientist to employ the screening method through apoptosis so that the agents that induce unspecific cytotoxicity can be excluded without wasting time and resources. Broad range of natural substance which has the potential to induce apoptosis for different tumor cell of origin has been documented., These natural substances of clinical values are often present in plant sources and consumed by humans in lesser quantities. Hence, it becomes essential to probe for the inducers of apoptosis from such plant resources.
Antioxidant available from nature possesses a broad range of biochemical functions including inhibiting reactive oxygen species, scavenging free radicals, and intracellular redox potential modifications. Recently, Ali and Chaudhary  have reviewed F. hispida based on its pharmacognostic and ethnomedicinal properties and concluded that further studies (preclinical and clinical) need to be performed to elucidate the maximum potential of this plant.
Pratumvinit et al. had extracted the methanol fractions from the dried stems of F. hispida L. and screened for anticancer activity (MTT assay with more dilution, colony forming assay, and cell cycle analysis) in four human breast cancers cell lines (SKBR3, MDA-MB435, MCF7, and T47D). The study had demonstrated the presence of cell line growth inhibition in dose-dependent manner, an emergence of apoptotic populations (G1 subset phase of the cell cycle) and suggested that F. hispida is beneficial in the treatment of breast cancer, especially in T47D. In similar, our study also confirms that the ethanolic leaf extract also provides anticancer activity against human colorectal cancer (HT-29 cell line) during the G0/G1 phase. In our study, we had used Muse Millipore Cell analyzer for assessing the cell cycle phase only using forward scattering measurement and their results are exported in that format. Hence, sub-G1 phase is not shown in standard format. The above similar study had also determined the IC50 value of the extract to be 110.3 μg/ml and in our study, we had observed to be at 125 μg/ml. The ideology behind the choice of using this F. hispida Linn. extracts against HT-29 cells would be the presence of hormone (estrogen or progesterone)-based target present in this cell line, but the exact mechanism of apoptosis still remains unclear.
Bhagat et al., in the year 2010, investigated the leaf extraction process and assessed the in vitro cytotoxicty against oral (KB) and colon (COLO 205) human cancer cell lines. They had also proved that the growth inhibition demonstrated by all extracts and fractions were in dose-dependent manner and concluded that the F. hispida have ideal cytotoxicity against oral and human colon cancer cells; moreover, the active molecule are present in nonpolar nature. The above findings correlate with our findings regarding the growth inhibition.
Singh R et al. reported that the methanolic leaves extract of F. hispida in an artificially created wound in animals had caused excellent wound healing process activities and proposed that leaves are responsible for the upregulation of collagen in the wound site causing healing apart from other studies , as in contrast to our study.
Abubakar et al. analysed the synergistic efficacy of antiproliferative effects caused by individual alkaloid extracts of Ficus fistulosa, F. hispida, and Ficus schwarzii combined with d-and g-tocotrienols against colorectal adenocarcinoma (HT-29) cells, lung adenocarcinoma (A549), and human brain glioblastoma (U87MG). This paper confirms that leaves of F. hispida provides a higher concentration of alkaloids compared to other species but both the bark and the leaf extract had less potency and cytotoxicity against HT-29 cells as contrast to our study.
| Conclusion|| |
This study demonstrates that F. hispida Linn. ethanolic extract alone induce growth inhibition effect on the HT-29 cell lines in a dose-dependent manner. Earlier reports had shown the cytotoxic efficiency of individual F. hispida Linn. to be low or excellent with the synergistic effect of another compound. Our study concludes that apoptosis plays role in F. hisida Linn. induced antineoplastic activities which might be due to the presence of effective phytoconstituents such as alkaloids, flavonoids, polyphenols, tannins, and saponins in the test drug which are normally extracted in higher quantities compared to other parts of the plant. In our study, we did not observe any wound healing assay positive but the past literature had shown positive results in animals. The limitation of the current study is that annexin V-FITC/PI flow cytometry assay was not performed to confirm the cell apoptosis as a additional confounding information due to economic constraint. Hence, further studies are required at preclinical and clinical level following a molecular investigation to explain the bioactive components and its associated mechanism that could trigger growth inhibition through this herbal extract.
I would like to acknowledge Dr. M. G. R Educational and Research Institute (University), Maduravoyal, Chennai, for providing us the necessary facilities to carry out this work.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kutluk T, Kars A. General Knowledge about Cancer. Ankara: Turkey Cancer Investigation and Fight Society Publications; 1998. p. 7-15.
Millan A, Huerta S. Apoptosis-inducing factor and colon cancer. J Surg Res 2009;151:163-70.
Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, et al.
The growing burden of cancer in India: Epidemiology and social context. Lancet Oncol 2014;15:e205-12.
Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP, et al.
Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000;6:909-19.
Golder S, Wright K, Rodgers M. Failure or success of search strategies to identify adverse effects of medical devices: A feasibility study using a systematic review. Syst Rev 2014;3:113.
Owoabi J, Omogbai EK, Obasuyi O. Antifungal and antibacterial activities of the ethanolic and aqueous extract of Kigelia Africana
) stem bark. Afr J Biotechnol 2007;6:882-5.
Vasanthi P, Ganapathy M, Evanjelene VK, Ayyavuv N, Angamuthu J. Phytochemical screening and antioxidant activity of extracts of the leaf and bark of Albizia lebbeck
(Benth). Acad J Med Plant 2014;2:26-31.
Xu Y, Ge R, Du J, Xin H, Yi T, Sheng J, et al.
Corosolic acid induces apoptosis through mitochondrial pathway and caspase activation in human cervix adenocarcinoma HeLa cells. Cancer Lett 2009;284:229-37.
Ripu M, Kunwar I, Rainer WB. Ficus (Fig) species in Nepal a review of diversity and indigenous uses. J Ecol Appl 2006;11:85-7.
Rahmatullah M, Ferdausi D, Mollik MA, Azam MN, Rahman MT, Jahan R. Ethnomedicinalsurvey of Bheramara area in Kushtia district, Bangladesh. Am Eurasian J Sustain Agric 2009a; 3:534-41.
Rahmatullah M, Mollik MA, Rashid MH, Tanzin R, Ghosh KC, Rahman H, et al
. A comparative analysis of medicinal plants used by folk medicinal healers in villages adjoining the Ghaghat, Bangali and Padma Rivers of Bangladesh. Am Eurasian J Sustain Agric 2010;4:70-85.
Mandal SC, Ashok Kumar CK. Studies on anti-diarrhoeal activity of Ficus hispida
leaf extract in rats. Fitoterapia 2002;73:663-7.
Mandal SC, Saraswathi B, Kumar CK, Mohana Lakshmi S, Maiti BC. Protective effect of leaf extract of Ficus hispida
Linn. against paracetamol-induced hepatotoxicity in rats. Phytother Res 2000;14:457-9.
Shahreen S, Banik J, Hafiz A, Rahman S, Zaman AT, Shoyeb MA, et al.
Antihyperglycemic activities of leaves of three edible fruit plants (Averrhoa carambola, Ficus hispida
and Syzygium samarangense
) of Bangladesh. Afr J Tradit Complement Altern Med 2012;9:287-91.
Peraza-Sánchez SR, Chai HB, Shin YG, Santisuk T, Reutrakul V, Farnsworth NR, et al.
Constituents of the leaves and twigs of Ficus hispida
. Planta Med 2002;68:186-8.
Pratumvinit B, Srisapoomi T, Worawattananon P, Opartkiattikul N, Jiratchariyakul W, Kummalue T.In vitro
antineoplastic effect of Ficus hispida
plant against breast cancer cell lines. J Med Plants Res 2009;3:255-61.
Ghosh R, Sharatchandra K, Rita S, Thokchom IS. Hypoglycemic activity of Ficus hispida
(bark) in normal and diabetic albino rats. Indian J Pharmacol 2004;36:222-5. [Full text]
Murti K, Lambole V, Panchal M. Effect of Ficus hispida
L. on normal and dexamethasone suppressed wound healing. Braz J Pharm Sci 2011;47:4.
Shanmugarajan TS, Arunsunda MC. Cardioprotective effect of Ficus hispida
Linn. on cyclophosphamide provoked oxidative myocardial injury in a rat model. Int J Pharmacol 2008;4:78-87.
Sivaraman D, Muralidharan P, Panneerselvam P. Ameliorating effect of ethanol leaf extract of Ficus hispida
Linn. on amyloid beta Aβ (25-35) induced cognitive deficits and oxidative stress in Alzheimer's mice. Int J Pharmacol 2012;8:212-23.
Huong VN, Trang VM. Hispidin. A strong anticancer agent isolated from the leaves of Ficus hispida
L. Tap Chi Hoa Hoc 2006;44:345-9.
Khan MS, Siddiqui AA, Javed K. Chemical investigation of the leaves of Ficus hispida. Indian J Nat Prod 1991;6:14-5.
Mousavi SH, Moallem SA, Mehri S, Shahsavand S, Nassirli H, Malaekeh-Nikouei B, et al.
Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol 2011;49:1039-45.
Olaru OT, Venables L, VAN DE Venter M, Nitulescu GM, Margina D, Spandidos DA, et al.
Anticancer potential of selected Fallopia
Adans species. Oncol Lett 2015;10:1323-32.
Cetintas VB, Kucukaslan AS, Kosova B, Tetik A, Selvi N, Cok G, et al.
Cisplatin resistance induced by decreased apoptotic activity in non-small-cell lung cancer cell lines. Cell Biol Int 2012;36:261-5.
Zhang JH, Yu J, Li WX, Cheng CP. Evaluation of Mn2+stimulated and Zn2+inhibited apoptosis in rat corpus luteal cells by flow cytometry and fluorochromes staining. Chin J Physiol 1998;41:121-6.
Aigner T. Apoptosis, necrosis, or whatever: How to find out what really happens? J Pathol 2002;198:1-4.
El-Menshavi B, Fayad W, Mahmoud K, El-Hallouty S, El-Manavaty M, Olofsson M and Linder S. Screening of natural products for therapeutic activity against solid tumor. Indian J. Exp. Biol2 010;48: 258-64.
Mathur R, Gupta SK, Mathur SR, Velpandian T. Anti-tumor studies with extracts of Calotropis procera
(Ait.) R. Br. Root employing Hep2 cells and their possible mechanism of action. Indian J Exp Biol 2009;47:343-8.
Shiezadeh F, Mousavi SH, Amiri MS, Iranshahi M, Tayarani-Najaran Z, Karimi G, et al.
Cytotoxic and apoptotic potential of Rheum turkestanicum
Janisch root extract on human cancer and normal cells. Iran J Pharm Res 2013;12:811-9.
Taraphdar A, Roy M, Bhattacharya R. Natural products as inducers of apoptosis implication for cancer therapy and prevention. Curr Sci 2001;80:1388-96.
Ali M, Chaudhary N. Ficus hispida Linn.: A review of its pharmacognostic and ethnomedicinal properties. Pharmacogn Rev 2011;5:96-102.
Bhagat M, Arora JS, Saxena AK. Studies on in vitro
cytotoxicity of Ficus hispida
leaves. Asian J Bio Sci 2010;4:286-8.
Singh R, Thakur P, Semwal A, Kakar S. Wound healing activity of leaf methanolic extract of Ficus hispida
Linn. Afr J Pharm Pharmacol 2014;8:21-3.
Abubakar IB, Lim KH, Loh HS. Alkaloid extracts of Ficus species and palm oil-derived tocotrienols synergistically inhibit proliferation of human cancer cells. Nat Prod Res 2015;29:2137-40.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]